Korsana Biosciences, Inc. (KRSA) vs Intellia Therapeutics, Inc. (NTLA)
- Korsana Biosciences, Inc. KRSA 32.38 −3.77%
- Intellia Therapeutics, Inc. NTLA 11.42 +0.71%
Korsana Biosciences, Inc. and Intellia Therapeutics, Inc. are both Biotechnology companies. Korsana Biosciences, Inc. and Intellia Therapeutics, Inc. are of similar size ($1.6B and $1.5B). Korsana Biosciences, Inc. grew revenue faster over the last twelve months: 30.8% against 12.6%. Korsana Biosciences, Inc. has the higher net margin (0.00% vs −672.2%) and the lower return on invested capital (−115.4% vs −91.3%). Across the 16 metrics below, Intellia Therapeutics, Inc. leads on 9 and Korsana Biosciences, Inc. on 7.
Valuation
Profitability
| Metric | KRSA | NTLA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (711.66%) | 0.00% |
| Net margin | 0.00% | (672.16%) | 0.00% |
| Free cash flow margin | 0.00% | (585.82%) | 0.00% |
| Return on equity | (98.22%) | (55.44%) | (56.36%) |
| Return on assets | (82.29%) | (45.55%) | (48.04%) |
| Return on invested capital | (115.40%) | (91.28%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack